JKAP, which modulates the differentiation of CD4+ T cells, is decreased in AD, while Th17 populations are elevated, creating a pro-inflammatory environment that exacerbates synaptic dysfunction and phosphorylated tau pathology (76). This evidence concerns the gene CD4 and Alzheimer disease.